Terms: = Cervical cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Clinical Outcome
3 results:
1. Identification of CD28 and pten as novel prognostic markers for cervical cancer.
Shen F; Zheng H; Zhou L; Li W; Liu J; Xu X
J Cell Physiol; 2019 May; 234(5):7004-7011. PubMed ID: 30362552
[TBL] [Abstract] [Full Text] [Related]
2. outcomes of patients with metastatic cervical cancer in a phase I clinical trials program.
Hou MM; Liu X; Wheler J; Naing A; Hong D; Bodurka D; Schmeler K; Tsimberidou A; Janku F; Zinner R; Piha-Paul S; Hu CY; Lu K; Kurzrock R; Fu S
Anticancer Res; 2014 May; 34(5):2349-55. PubMed ID: 24778042
[TBL] [Abstract] [Full Text] [Related]
3. Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma.
Zhou J; Roh JW; Bandyopadhyay S; Chen Z; Munkarah AR; Hussein Y; Alosh B; Jazaerly T; Hayek K; Semaan A; Sood AK; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):344-8. PubMed ID: 22871469
[TBL] [Abstract] [Full Text] [Related]
